# WonderTx Landing Page Growth Score — YC S26

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-s26/wondertx
Source observed: 2026-10-15T19:33:05.332Z
Last checked: 2026-10-20T07:17:40.988+00:00
Indexed: 2026-10-15T23:06:57.566+00:00

---

# WonderTx Landing Page Growth Score

[← Back to YC S26](https://www.lazyweb.com/yc-s26)

[WonderTx](https://wondertx.ai/)

We assess WonderTx’s landing page in Lazyweb’s YC S26 Growth Score report. WonderTx describes its product as **“Extrapolative AI to unlock first-in-class drugs, replacing needles with pills.”** The report evaluates the landing page’s call to action, trust signals, information hierarchy, mobile experience, and value proposition.

## Overall score

- **Growth score:** 46 of 100
- **Updated:** Sep 20, 2026
- **Weakest category:** CTA
- **Overall ranking:** #6 of 6 assessed companies

### Overall ranking

1. [Chugai Pharmabody / Terray Therapeutics — 63](https://www.lazyweb.com/growth-score/site/terraytx.com)
2. [Isomorphic Labs — 57](https://www.lazyweb.com/growth-score/site/isomorphiclabs.com)
3. [Gate Bioscience — 55](https://www.lazyweb.com/growth-score/site/gatebio.com)
4. [Insilico Medicine — 54](https://www.lazyweb.com/growth-score/site/insilico.com)
5. [Iambic Therapeutics — 52](https://www.lazyweb.com/growth-score/site/iambic.ai)
6. WonderTx — 46

[Fix CTA](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Category scores

| Category | Score | Assessment |
|---|---:|---|
| [CTA](https://www.lazyweb.com/yc-s26/wondertx#gs-cta) | 32 | Poor |
| [Trust](https://www.lazyweb.com/yc-s26/wondertx#gs-trust) | 35 | Poor |
| [Information hierarchy](https://www.lazyweb.com/yc-s26/wondertx#gs-information_hierarchy) | 52 | Fair |
| [Mobile web](https://www.lazyweb.com/yc-s26/wondertx#gs-mobile_web) | 52 | Fair |
| [Value props](https://www.lazyweb.com/yc-s26/wondertx#gs-value_props) | 58 | Fair |

## Score over time

The report includes a score-history chart for WonderTx and the comparison companies: Gate Bioscience, Chugai Pharmabody / Terray Therapeutics, Insilico Medicine, Iambic Therapeutics, and Isomorphic Labs. The highlighted WonderTx series ends at 46 on Sep 20, 2026.

## CTA — 32, Poor

We evaluate whether the primary call to action earns the click through its copy, size, verb, and cost-feel.

### Findings

- There is no CTA anywhere in the fold.
- The only navigation links are **About** and **Blog**.
- The hero attracts attention but provides no outlet for that attention.

### CTA comparison

1. Chugai Pharmabody / Terray Therapeutics — 55
2. Gate Bioscience — 44
3. Insilico Medicine — 44
4. Iambic Therapeutics — 42
5. Isomorphic Labs — 42
6. WonderTx — 32

### CTA rewrite studio

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-cta-writing) — Generate primary and secondary CTA options grounded in WonderTx’s offer and visitor objections.

## Trust — 35, Poor

We evaluate proof that a product is real, competent, and safe to try.

| Company | Trust read |
|---|---|
| WonderTx | No visible trust signal identified. |
| Gate Bioscience | No visible trust signal identified. |
| Chugai Pharmabody / Terray Therapeutics | Authentic lab photography of scientists and instruments in the hero collage. |
| Insilico Medicine | Pipeline table rows showing “Out-licensed to Exelixis” and “Out-licensed to Menarini,” with Phase I–III progress bars; the supplied text ends after “and”. |
| Iambic Therapeutics | No visible trust signal identified. |
| Isomorphic Labs | The report identifies implicit context that Isomorphic Labs may benefit from pre-existing familiarity among its target audience. |

### Trust comparison

1. Insilico Medicine — 72
2. Chugai Pharmabody / Terray Therapeutics — 52
3. Gate Bioscience — 42
4. Iambic Therapeutics — 42
5. Isomorphic Labs — 42
6. WonderTx — 35

[Build proof section](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-trust-signals) — Choose proof signals and get copy and placement for a stronger trust section.

## Information hierarchy — 52, Fair

We evaluate whether the design helps or inhibits the page’s message.

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/wondertx.ai.jpg?v=2026-09-20T08%3A00%3A58.803%2B00%3A00)

1. **Video card outranks headline.** The large media card dominates the fold and pushes the value proposition to the bottom edge, so the message reads second instead of first.
2. **About and Blog pills.** The only clickable elements in the fold are two exit links, so engaged visitors are routed away from conversion.

[View layout plan](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-information-hierarchy) — Turn these callouts into a sequenced page plan: keep, move, merge, or remove.

## Mobile web — 52, Fair

We evaluate the phone experience as a first-class experience.

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/wondertx.ai-mobile.jpg?v=2026-09-20T08%3A00%3A58.803%2B00%3A00)

- **Blog nav button.** The Blog label sits on the dark hero graphic and half-disappears, and neither navigation pill drives conversion.

[View mobile fixes](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-mobile-web) — Convert the mobile findings into a prioritized implementation checklist.

## Value props — 58, Fair

We evaluate whether the title, subtitle, and hero sell WonderTx’s true value.

### WonderTx’s headline

> Extrapolative AI to unlock first-in-class drugs, replacing needles with pills.

The report marks the headline as **underselling**.

### Working

- “Needles with pills” is vivid and concrete.
- The hero image shows the actual deliverable.
- The headline names a clear category outcome.

### Could improve

- Jargon-first ordering hides the payoff.
- There is no subhead or proof point.
- There are zero numbers or evidence in the fold.

### Value-proposition comparison

1. Isomorphic Labs — 72
2. Chugai Pharmabody / Terray Therapeutics — 68
3. Insilico Medicine — 64
4. WonderTx — 58
5. Gate Bioscience — 58
6. Iambic Therapeutics — 54

## Competitors

The report infers these competitors from product, audience, and value proposition:

1. [Chugai Pharmabody / Terray Therapeutics — terraytx.com — 63](https://www.lazyweb.com/growth-score/site/terraytx.com)
2. [Isomorphic Labs — isomorphiclabs.com — 57](https://www.lazyweb.com/growth-score/site/isomorphiclabs.com)
3. [Gate Bioscience — gatebio.com — 55](https://www.lazyweb.com/growth-score/site/gatebio.com)
4. [Insilico Medicine — insilico.com — 54](https://www.lazyweb.com/growth-score/site/insilico.com)
5. [Iambic Therapeutics — iambic.ai — 52](https://www.lazyweb.com/growth-score/site/iambic.ai)
6. WonderTx — 46

## Report tools

- [CTA rewrite studio](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-cta-writing)
- [Proof section builder](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-trust-signals)
- [Layout priority plan](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-information-hierarchy)
- [Mobile fix plan](https://www.lazyweb.com/backlog?site=wondertx.ai#opt-mobile-web)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Fwondertx&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Fwondertx). Opening a form does not execute a tool.